Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
MarketBeat.com
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals MarketBeat - Thu Aug 27, 7:35AM CDT

Canada Goose, Capital Clean Energy Carriers and SOPHiA Genetics have each seen unusual trading volume recently, driven by tariffs, LNG demand, and a strong earnings beat, respectively.

CCEC : 22.72 (-0.26%)
SOPH : 8.14 (-8.74%)
GOOS : 8.24 (+1.73%)
SOPHiA GENETICS Reports Second Quarter 2026 Results PR Newswire - Tue Aug 4, 5:45AM CDT

BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies PR Newswire - Tue Aug 4, 5:15AM CDT

BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS  (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics...

SOPH : 8.14 (-8.74%)
AZN : 162.70 (-1.11%)
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PR Newswire - Tue Jul 21, 7:00AM CDT

BOSTON and ROLLE, Switzerland , July 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today announced it will release its financial results...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting PR Newswire - Mon Jun 22, 7:25AM CDT

Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross Muken elected as new member of the Board ahead of his appointment as CEO effective July...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares PR Newswire - Fri Jun 19, 7:00AM CDT

BOSTON and ROLLE, Switzerland , June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares PR Newswire - Tue Jun 16, 8:21PM CDT

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares PR Newswire - Tue Jun 16, 3:20PM CDT

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting PR Newswire - Wed Jun 10, 7:00AM CDT

Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center PR Newswire - Thu Jun 4, 7:00AM CDT

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology

SOPH : 8.14 (-8.74%)

Barchart Exclusives

How to Play the Post-Earnings Selloff in Marvell Technology Stock Barchart - Fri Aug 28, 3:13PM CDT
Marvell shares sink despite a strong Q2 print and future guidance. BofA and options data suggest buying the dip in MRVL stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.